Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage therapy in chronic prosthetic joint infection
NCT05269134Phase 2Withdrawn
- Sponsor
- BiomX
- Start
- Mar 2023
- Primary completion
- Jul 2025
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of bacteriophages in prosthetic joint infection (PJI), sponsored by BiomX. Planned start Mar 2023; status: withdrawn.
02
Drugs
bacteriophages
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT05269134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269134.